PT785794E - Composicoes entericas revestidas de derivados de 1,5-benzodiazepina tendo actividade antagonistica ou agonistica de cck - Google Patents

Composicoes entericas revestidas de derivados de 1,5-benzodiazepina tendo actividade antagonistica ou agonistica de cck

Info

Publication number
PT785794E
PT785794E PT95935725T PT95935725T PT785794E PT 785794 E PT785794 E PT 785794E PT 95935725 T PT95935725 T PT 95935725T PT 95935725 T PT95935725 T PT 95935725T PT 785794 E PT785794 E PT 785794E
Authority
PT
Portugal
Prior art keywords
cck
antagonistic
covered
agonistic activity
benzodiazepine derivatives
Prior art date
Application number
PT95935725T
Other languages
English (en)
Inventor
Elizabeth Ellen Sugg
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Publication of PT785794E publication Critical patent/PT785794E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT95935725T 1994-10-14 1995-10-13 Composicoes entericas revestidas de derivados de 1,5-benzodiazepina tendo actividade antagonistica ou agonistica de cck PT785794E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9420748A GB9420748D0 (en) 1994-10-14 1994-10-14 1,5 benzodiazepine derivatives

Publications (1)

Publication Number Publication Date
PT785794E true PT785794E (pt) 2002-06-28

Family

ID=10762855

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95935725T PT785794E (pt) 1994-10-14 1995-10-13 Composicoes entericas revestidas de derivados de 1,5-benzodiazepina tendo actividade antagonistica ou agonistica de cck

Country Status (11)

Country Link
EP (1) EP0785794B1 (pt)
JP (1) JP3907700B2 (pt)
AT (1) ATE210986T1 (pt)
AU (1) AU3763495A (pt)
DE (1) DE69524781T2 (pt)
DK (1) DK0785794T3 (pt)
ES (1) ES2170168T3 (pt)
GB (1) GB9420748D0 (pt)
PT (1) PT785794E (pt)
SI (1) SI0785794T1 (pt)
WO (1) WO1996011701A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6558952B1 (en) * 1992-12-14 2003-05-06 Waratah Pharmaceuticals, Inc. Treatment for diabetes
JP4530433B2 (ja) * 1996-05-07 2010-08-25 プリヴァ・ディー・ディー 脂質及びグルコースの代謝疾患治療のための方法及び組成物
CR20180413A (es) 2016-02-05 2018-12-04 Denali Therapeutics Inc Inhibidores de la proteína quinasa 1 que interactua con el receptor
WO2018107060A1 (en) 2016-12-09 2018-06-14 Denali Therapeutics Inc. Compounds, compositions and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR890100827A (el) * 1988-12-21 1991-03-15 Abbott Lab Μέ?οδος παραγωγής παραγώγων τετραπεπτιδίων ως ανταγωνιστών CCK.
GEP20001968B (en) * 1992-01-21 2000-03-05 Glaxo Spa Arilthio Compounds as Antibacterial and Antiviral Agents
GB9307833D0 (en) * 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin

Also Published As

Publication number Publication date
JPH10511930A (ja) 1998-11-17
DE69524781T2 (de) 2002-06-20
DK0785794T3 (da) 2002-03-18
GB9420748D0 (en) 1994-11-30
WO1996011701A1 (en) 1996-04-25
ATE210986T1 (de) 2002-01-15
EP0785794B1 (en) 2001-12-19
AU3763495A (en) 1996-05-06
DE69524781D1 (de) 2002-01-31
ES2170168T3 (es) 2002-08-01
SI0785794T1 (en) 2002-08-31
JP3907700B2 (ja) 2007-04-18
EP0785794A1 (en) 1997-07-30

Similar Documents

Publication Publication Date Title
YU13695A (sh) Upotreba 2-fenil-3-aroilbenzotiofena i njihove farmaceutske formulacije
SE8804629D0 (sv) New therapeutically active compounds
TR199802698T2 (xx) Valsartan�n kat� oral doz formlar�.
IL131818A (en) Pharmaceutical composition for oral administration of a n-piperidino-3-pyrazolecarboxamide derivative, its salts and solvates and their preparation
HUP9802221A2 (hu) Parazitaellenes hatású markfortin- és paraherkvamidszármazékok
EP0382077A3 (de) Diarylsubstituierte heterocyclische Verbindung, ihre Herstellung und Arzneimittel und Kosmetika daraus
ATE89547T1 (de) Dopamin-vorlaeufer.
SE8804628D0 (sv) New compounds
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
PH27446A (en) Compound with gastric acid inhibitory effect
IT9019112A1 (it) Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
PT785794E (pt) Composicoes entericas revestidas de derivados de 1,5-benzodiazepina tendo actividade antagonistica ou agonistica de cck
IT8621097A1 (it) Derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative composizioni farmaceutiche
IT9021021A0 (it) Composizioni farmaceutiche per la somministrazione orale di irudina
IT1243702B (it) Composti ad attivita' nootropa, procedimento per la loro preparazione e relative composizioni farmaceutiche
FR2685204B1 (fr) Compositions pharmaceutiques pour l'administration transcutanee de la fenfluramine.
JO1653B1 (en) The current benzimidazole is a therapeutically active method for preparing it
ITPD920141A0 (it) Formulazione farmaceutiche per la somministraziane orale di calcitoni-na
FR2731221B1 (fr) Nouveaux derives de l'ethyl-1 dihydro-1, 2 oxo-2 methylamino-3 quinoxaline, leur utilisation a titre de medicament et les compositions pharmaceutiques les comprenant
FR2655344B1 (fr) Derives heterocycliques d'acylaminothiazoles, leur preparation et compositions pharmaceutiques en contenant.
ITMI912238A1 (it) Composti ad attivita' mucolitica e antisettica, procedimento per la loro preparazione e relative composizioni farmaceutiche
IT8820927A0 (it) Composto ad attivita'antiinfiammatoria, procedimento per la sua preparazione e relative composizioni farmaceutiche.
IT1222140B (it) Composti ad attivita' antivirale,procedimento per la loro preparazione e relative composizioni farmaceutiche
JO1664B1 (en) The compound has the effect of immobilizing gastric acid and the process of preparing it